CANY
TNDM icon

Caxton Associates (New York)’s Tandem Diabetes Care TNDM Stock Holding History

Caxton Associates (New York)’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,851
Closed -$279K – 703
2021
Q4 		$279K Buy
+1,851
New +$250K 0.03% 431
2020
Q2 		– Sell
-4,395
Closed -$283K – 623
2020
Q1 		$283K Buy
+4,395
New +$308K 0.05% 271

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Caxton Associates (New York)'s TNDM Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 1,851 shares — an estimated $279K sold.

Caxton Associates (New York) first reported a position in TNDM in Q1 2020 and held it in 2 quarters. The position peaked at $283K in Q1 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,851 Tandem Diabetes Care shares in Q1 2022, an estimated $279K.
  • Caxton Associates (New York) first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 2 quarters.
  • Caxton Associates (New York)'s Tandem Diabetes Care position peaked at $283K in Q1 2020.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.